Archive

Category Archives for "News"

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in Close of $11 Million Underwritten Public Offering and NASDAQ Uplisting

lexaria bioscience logo

Press Release – New York, NY – January 14, 2021 – Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: “LEXX”), in a closing of an underwritten public offering of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit. Lexaria uses proprietary drug delivery technology, DehydraTECH™, improving the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. The gross proceeds from the offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses.

The offering was made pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC).

H.C. Wainwright & Co. acted as the sole book-running manager for the Offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Avital Perlman, and associate Jacob Tabman and law clerk Zachary Weiss.

Partner Andrew M.J. Bernstein to Present CLE on “Preparing Your Client to Testify Before a Grand Jury” for Lawline

Press Release – New York, NY – January 11, 2021 – Andrew M. J. Bernstein, Partner and leader of Sichenzia Ross Ference LLP’s White-Collar Defense and Investigations practice, will be presenting “Preparing Your Client to Testify Before a Grand Jury” on Monday January 25, 2021 at 11:30 A.M. EST. The CLE course is Mr. Bernstein’s third collaboration with Lawline in the past six months.

The course will cover how to effectively prepare a client, who is either a defendant in a criminal case or a target of a government investigation, to testify before a grand jury. The course will be live-streamed and a recording will be available any time after online.

SIGN UP HERE

Sichenzia Ross Ference LLP Represents KULR Technology Group, Inc. in $8.0 Million Registered Direct Offering 

kulr logo

Press Release – New York, NY – January 4, 2021 – Sichenzia Ross Ference LLP announced today that it represented KULR Technology Group, Inc. (OTCQB: KULR), in a registered direct offering of 6,400,001 shares of common stock and warrants at a purchase price of $1.25 per share and accompanying warrant. The gross proceeds for the offering were $8.0 million.

continue reading >>

Sichenzia Ross Ference LLP Represents SunHydrogen in $9.0 Million Warrant Exercise Transaction

sun hydrogen logo

Press Release – New York, New York – December 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented SunHydrogen, Inc. (OTC: HYSR), in a transaction in which a warrant holder exercised its registered warrants for the purchase of 120,000,000 shares of common stock at an exercise price of $0.075 per share, and received unregistered warrants to purchase up to 132,000,000 shares of common stock at an exercise price of $0.075 per share. The shares issued upon exercise of the registered warrants were registered on a shelf registration statement on Form S-3. H.C. Wainwright & Co., LLC acted as the exclusive placement agent for the transaction.

continue reading >>

Sichenzia Ross Ference LLP Represents H.C. Wainwright in $2.9 Million Public Offering of Staffing 360 Solutions, Inc.

staffing solutuons logo

Press Release – New York, NY – December 29, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as sole book-running manager in a $2.9 million public offering of the common stock of Staffing 360 Solutions, Inc. (NASDAQ: “STAF”), a company engaged in the execution of an international buy-integrate-build strategy through the acquisition of domestic and international staffing organizations in the United States and United Kingdom. The offering consisted of 4,816,665 shares of common stock, at a public offering price of $0.60 per share, for aggregate gross proceeds of approximately $2.9 million.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $26.4 Million Public Offering of Common Stock of Greenwich LifeSciences, Inc. 

greenwich lifesciences logo

Press Release – New York, NY – December, 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp., as a sole bookrunner in the follow on public offering of 660,000 shares of the common stock of Greenwich LifeSciences, Inc. (NASDAQ: GSLI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.  The shares were sold to the public at a price of $40.00 per share for gross proceeds of approximately $26,400,000. This offering was made pursuant to a registration statement on Form S-1 (File No. 333-251366) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and subsequently declared effective on December 17, 2020 and a registration statement on Form S-1 (File No. 333-251438) previously filed with the SEC and immediately declared effective on December 17, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $5.5 Million Public Offering of Common Stock of ENDRA Life Sciences Inc.

endra life sciences logo

Press Release – New York, NY – December 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, as sole underwriter in the follow on public offering of the common stock of ENDRA Life Sciences (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. The offering consisted of 7,857,286 shares of common stock, and the gross proceeds from the offering were $5,500,100, before deducting underwriting discounts and estimated offering expenses.

continue reading >>

Client Alert: New York Adopts Revised Regulations for Individuals of Registered Investment Advisers

OVERVIEW

In an effort to modernize its registration function, to better conform to the federal securities registration regime, to cure industry confusion as to certain registration requirements and to better track exam requirement compliance of thousands of investment adviser representatives (“IARs”) providing investment advice to New Yorkers, the New York Investor Protection Bureau of the Department of Law (“Department”) has proposed revisions to its current regulations.

continue reading >>

Sichenzia Ross Ference LLP Represents Wunong Net Technology Company Limited in $30 Million Initial Public Offering

wunong net technology logo

Press Release – New York, NY – December 17, 2020 – Sichenzia Ross Ference LLP announced today that it represented Wunong Net Technology Company Limited (Nasdaq: WNW) in a $30 million initial public offering of its ordinary shares. Wunong Net Technology Co. Ltd. (“Wunong”) is a China-based e-commerce company which uses an innovative e-platform to sell a myriad of food products. The offering was comprised of 5,000,000 ordinary shares of Wunong at a price of US$5.00 per share to the public for a total of US$25,000,000 of gross proceeds to Wunong. In addition, the underwriters have purchased 999,910 ordinary shares from a selling shareholder for US$4,999,550 for a total of US$29,999,550 in total gross proceeds from the offering.

continue reading >>

Partner Andrew M.J. Bernstein Presented CLE on Initial Appearances in Criminal Matters in the Age of COVID-19

Press Release – New York, NY – December 8, 2020 – Andrew M. J. Bernstein, Partner and leader of Sichenzia Ross Ference LLP’s White-Collar Defense and Investigations practice, presented “Making an Initial Appearance in a NY Criminal Case in the COVID-19 Era,” last Monday, November 30, 2020. This is Mr. Bernstein’s second collaboration with Lawline this year. The CLE course was filmed live and is now available for online viewing anytime by clicking here.

Currently throughout New York, most federal and state courts are conducting initial proceedings in criminal cases remotely. This CLE presentation focused on how to effectively represent clients at remote initial presentments or arraignments in New York federal and state criminal matters. Mr. Bernstein further offered his expertise and insights from his recent successful remote appearances.

Mr. Bernstein’s next CLE program, hosted by Lawline, is scheduled for January 25, 2021, and is entitled “Preparing Your Client to Testify Before a Grand Jury.”

Sichenzia Ross Ference LLP Represents SunHydrogen in $9.0 Million Registered Direct Offering

sun hydrogen logo

Press Release – New York, New York – December 3, 2020 – Sichenzia Ross Ference LLP announced today that it represented SunHydrogen, Inc. (OTC: HYSR), in a registered direct offering of 120,000,000 shares of its common stock and short-term warrants to purchase 120,000,000 shares of common stock.

The combined purchase price for one share of common stock and a warrant to purchase one share of
common stock was $0.075. The gross proceeds from the offering were $9,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents HF Enterprises Inc. in $15.1 Million Initial Public Offering and Nasdaq Listing

hf enterprises inc. logo

Press Release – New York, NY – November 30, 2020 – Sichenzia Ross Ference LLP announced today that it has represented HF Enterprises Inc. (“HFEN” or the “Company”) in connection with the Company’s  initial public offering of common stock and listing on the Nasdaq Capital Market. HFEN is a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities with operation in the United States, Singapore, Hong Kong, Australia and South Korea. The initial public offering consisted of 2,160,000 shares of common stock at a public offering price of $7.00 per share. The gross proceeds were approximately $15.1 million, before deducting offering expenses. The Company’s common stock commenced trading on the Nasdaq Capital Market on November 24, 2020 under the symbol “HFEN”.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./ Alliance Global Partners as Placement Agent in $15M Registered Direct Offering of Arcimoto, Inc.

arcimoto logo

Press Release – New York, NY – November 24, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as lead placement agent in a registered direct offering of 1,132,075 shares of common stock of Arcimoto, Inc. (NASDAQ: FUV), an electric vehicle developer and manufacturer. The offering price was $13.25 per share for gross proceeds of $15 million. The offering was made pursuant to a shelf registration statement previously filed with Securities and Exchange Commission on October 3, 2018, and declared effective on October 17, 2018 by the Securities and Exchange Commission.

continue reading >>

Founding Partner Marc J. Ross, Esq.  Quoted Regarding Cannabis SPACs Post U.S. Presidential Elections

Press Release – New York, NY – November 23 2020 – Sichenzia Ross Ference LLP founding partner Marc J. Ross, Esq. was recently quoted in an article titled “Election Brings Questions for Cannabis SPACs.” The article discusses what lies ahead for cannabis companies after the recent United States presidential election, in general, and the prospects for acquisition opportunities (SPACs) in the cannabis industry, in particular. Now that the Biden-Harris ticket has won, and Joe Biden will occupy the White House, Ross expects better days for the cannabis industry, where the ‘early movers’ often encountered obstacle after obstacle as a result of the hostile federal environment.

continue reading >>

2020 Income Tax Rates and Deductions

Sichenzia Ross Ference has prepared a tax chart showing all proposed tax changes under Biden vs. current under Trump.

It is a downloadable PDF titled “2020 Income Tax Rates and Deductions” that you can access by clicking the link below.

Click here for 2020 income tax rates and deductions

 

This material has been prepared for informational purposes only and is not intended to provide, and should not be relied on as, specific tax, legal or accounting advice. Each individual’s situation is unique and may require customized advice.  We recommend that you consult your own tax and accounting advisors before engaging in any transaction.  Please contact Robert M. Birnbaum, Esq., or Carolyn M. Glynn, Esq. if you are interested in learning more about this or other estate planning topics.

Year-end Tax Strategies to Consider Now

Whether you anticipate your income taxes to increase next year due to higher earnings or changes due to tax legislation, consider the following before December 31.

To offset capital gains:

  • Harvest your losses by selling taxable investments.
  • Harvest your gains by selling taxable investments if you have capital loss carryovers or year-to-date losses for the current year. (Beware the IRS “wash sale” rule.)

Defer income and accelerate deductions:

  • If possible, defer income and the sale of capital gain property until 2021 or later to postpone taxable income to the following year.
  • Bunch itemized medical expenses in the same year in order to meet the threshold percentage of your adjusted gross income to claim such deductions.
  • In December, make your January mortgage payment (i.e. the payment due no later than January 15) so that you can deduct the interest on your 2020 tax return.
  • If you have concerns that you may be subject to the Alternative Minimum Tax (AMT), seek professional tax guidance before deferring income or accelerating deductions, as your AMT status could limit your ability to benefit from these actions.
  • For 2020 only, consider not taking your RMD (CARES Act provision) if you are in a higher income tax bracket in 2020 than you expect to be in 2021 or future years.

Seize retirement planning opportunities and avoid missteps:

  • Maximize your IRA contributions. You may be able to deduct annual contributions of up to $6,000 to your traditional IRA and $6,000 to your spouse’s IRA. 
  • If you are 50 or older, take advantage of catching up on IRA contributions and certain qualified retirement plans. You may be able to contribute and deduct an additional $1,000.
  • Required Minimum Distributions are suspended for 2020 under the CARES Act but consider whether to take your RMD if you anticipate being in a higher tax bracket in future years.
  • Consider increasing or maximizing your 401(k) and retirement account contributions. 
  • Consider contributions to a Roth 401(k) plan (if your employer allows and you are in a lower income tax bracket now than you expect to be in the future).
  • Avoid mandatory tax withholding by making a direct rollover distribution to an eligible retirement plan, including an IRA. (Avoid taking IRA distributions prior to age 59½ or a 10% early withdrawal penalty may apply.)
  • Consider setting up a Roth IRA for each of your children who have earned income.
  • Consider converting from a traditional IRA to a Roth IRA if in a low marginal income tax bracket. (Partial Roth IRA conversions are permissible.)
  • If you have been impacted by the COVID-19 pandemic as defined by the IRS, you may be eligible to take a COVID-19-related distribution from an eligible retirement plan. (The deadline for taking such a distribution is December 30, 2020, and you may withdraw up to an aggregate limit of $100,000 from all eligible plans and IRAs.) 
  • If you have business losses that flow through to your individual tax return in 2020, consider a Roth conversion or harvest capital gains to create income that is offset by the business loss.

Gifting and charitable strategies:

  • Consider making gifts of up to $15,000 per person and use assets likely to appreciate.
  • Make a charitable donation (cash or even old clothes) before the end of the year.
  • Use appreciated stock rather than cash when contributing to charities. 
  • If you are over 70½ in 2020 and would like to make a donation to charity from your IRA, you can donate up to $100,000 each year directly to qualified charities using a Qualified Charitable Distribution.
  • Set up a donor-advised fund for an immediate income tax deduction and provide immediate and future benefits to charity over time.
  • Consider “bunching” several years of charitable contributions into one year with a gift to a donor-advised fund to make your contributions more tax-efficient.

This material has been prepared for informational purposes only and is not intended to provide, and should not be relied on as, specific tax, legal or accounting advice. Each individual’s situation is unique and may require customized advice.  We recommend that you consult your own tax and accounting advisors before engaging in any transaction.  Please contact Robert M. Birnbaum, Esq., or Carolyn M. Glynn, Esq. if you are interested in learning more about this or other estate planning topics

Sichenzia Ross Ference LLP Recognized in U.S. News & World Report – “Best Lawyers List” for 2021

Press Release – New York, NY – November 18, 2020 –Sichenzia Ross Ference LLP is proud to be included in the 2021 list of “Best Law Firms” ranking issued by U.S. News & World Report. The firm was recognized as a top tier Metropolitan “Best Law Firm” in the Corporate Law practice area. Based on a rigorous evaluation process through consistent impressive ratings from clients and peers, “Best Law Firm” is a prestigious list in which the firm is honored to be recognized.

Sichenzia Ross Ference LLP Represents Bullfrog Gold in Acquisition of Assets from Barrick Gold and Concurrent C$22 Million Private Placement

bullfrog gold corp

Press Release – New York, NY – November 5, 2020 – Sichenzia Ross Ference LLP announced today that it represented Bullfrog Gold Corp.  (OTCQB: BFGC) (CSE: BFG) (“Bullfrog Gold”) in the acquisition of all of the equity interest of Bullfrog Mines LLC, the successor by conversion of Barrick Bullfrog Inc. Through the acquisition, Bullfrog Gold acquired rights to 1,500 acres adjoining the company’s Bullfrog Gold deposit. The firm also represented Bullfrog Gold in a concurrent private placement, entered into with Augusta Investments Inc. (“Augusta”) and certain individuals identified by Augusta, of 110,000,000 shares of common stock, and warrants to purchase 110,000,000 shares of common stock. The gross proceeds to Bullfrog Gold from this private placement were C$22,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Jupiter Wellness, Inc. in Initial Public Offering and Nasdaq Listing 

jupiter wellness

Press Release – New York, NY – November 3, 2020 – Sichenzia Ross Ference LLP announced today that it has represented Jupiter Wellness, Inc. (“Jupiter” or the “Company”), in connection with its Initial Public Offering of securities and listing on the Nasdaq Capital Markets. Jupiter is a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (CBD) via a multitude of convenient products. The Initial Public Offering consisted of 933,333 units consisting of one share of common stock and one warrant for gross proceeds of $7,000,000, before deducting offering expenses. The shares and warrants began trading on The NASDAQ Capital Market on October 30, 2020, under the symbol “JUPW and JUPWW, respectively.

continue reading >>

Eight Sichenzia Ross Ference LLP Attorneys Selected for Inclusion on 2020 Super Lawyers Lists

Press Release – New York, NY – November 3, 2020 – Sichenzia Ross Ference LLP, a leading corporate and securities law firm, announced today that eight of its attorneys were recognized by Super Lawyers Magazine for 2020. Those members include:

  • Founding Partner Michael H. Ference, Partner Richard J. Babnick, Jr. and Partner Sameer Rastogi were recognized for their work in the Securities Litigation category.
  • Founding Partner Gregory Sichenzia was recognized for his work in the Securities and Corporate Finance category.
  • Partner Andrew M. J. Bernstein was named a New York Metro Rising Star in the area of White Collar Criminal Defense.
  • Partner A.R. John Hitchings was named a New York Metro Rising Star in the area of Securities Litigation.
  • Partner Jay K. Yamamoto was named a New York Metro Rising Star in the area of Securities and Corporate Finance.
  • Counsel Owen A. Kloter was named a New York Metro Rising Star in the area of Business Litigation.

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners in $20 Million Public and Concurrent Registered Direct Offerings of Ring Energy

ring energy inc.

Press Release – New York, NY – October 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners  (“AGP”) as sole book-running manager in an underwritten public offering of 8,343,000 shares of common stock, 13,428,500 pre-funded warrants and 21,771,500 common warrants of Ring Energy, Inc. (NYSE American: REI). The gross proceeds to Ring Energy from this offering were approximately $15,240,000.  The firm also represented AGP as sole placement agent for a concurrent registered direct offering of 3,500,000 shares of common stock, 3,300,000 pre-funded warrants and 6,800,000 common warrants. The gross proceeds to Ring Energy from this offering were approximately $4,760,000.

continue reading >>

Sichenzia Ross Ference LLP Obtains Dismissal of $2.6 Million Contract Claims On Appeal

Press release- New York, NY – October 15, 2020 – Sichenzia Ross Ference LLP obtained dismissal today of $2.6 million in contractual claims against its corporate client and the company’s president in an appeal to the First Department, Appellate Division in Moiseenko et al. v. AGA Management Corp. et al.  The Supreme Court, New York County, had previously determined that the Plaintiffs’ employment contract was ambiguous as to whether Plaintiffs were owed $50,000 every other week, or $50,000 annually.  The First Department reversed the Supreme Court and granted summary judgment to the firm’s clients, dismissing the Plaintiff’s claim, holding that the “only reasonable reading” of the contract was that Plaintiffs were entitled to a $50,000 annual salary.

continue reading >>

Sichenzia Ross Ference LLP Represents H.C. Wainwright in $7.5 Million At-The-Market Offering of Ekso Bionics

ekso bionics

Press Release – New York, NY – October 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as sales agent in a $7.5 million At-The-Market Offering (“ATM”) of Ekso Bionics Holdings, Inc. (NASDAQ: “EKSO”) common stock.

The shares were registered on EKSO’s registration statement on Form S-3 (File No. 333-239203), which was declared effective by the SEC on June 26, 2020, and prospectus supplement relating to the ATM filed with the SEC on October 9, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $15 Million Initial Public Offering of Amesite Inc.

amesite logo

Press Release – New York, NY – September 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Laidlaw & Company (UK) Ltd. in the $15 million initial public offering of Amesite Inc., an artificial intelligence software company providing online educational programs for  K-12, college, university and business education, and upskilling. 3,000,000 shares were sold to the public at a price of $5.00 per share. Amesite’s common stock began trading on the Nasdaq Capital Market under the ticker symbol “AMST” on September 25, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $7.25 Million Initial Public Offering of Greenwich LifeSciences, Inc.

greenwich lifesciences logo

Press Release – New York, NY – September 29, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp., as a sole bookrunner in the initial public offering of 1,260,870 shares of the common stock of Greenwich LifeSciences, Inc. (NASDAQ: GSLI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. The shares were sold to the public at at a price of $5.75 per share for gross proceeds of approximately $7,250,000.

continue reading >>

Sichenzia Ross Ference Partner Andrew M. J. Bernstein, Esq. to Present Grand Jury CLE for Lawline

Sichenzia Ross Ference partner, and leader of the firm’s White-collar Defense and Investigations
practice, Andrew M. J. Bernstein will be presenting “New York State Grand Jury Practice for
Criminal Defense Attorneys” on Monday September 28, 2020 at 4:00 P.M. The CLE course,
presented by Lawline, will be live-streamed that day and the recording will be available any time
after online at https://www.lawline.com.

Focusing on New York State grand jury practice, the CLE course will cover: the law governing
grand juries, grand jury presentations, and how to effectively represent defendants who will be or
are considering testifying before a grand jury. Last month, Mr. Bernstein gave a similar
presentation for the New York State Bar Association.

SIGN UP HERE

Founding Partner Gregory Sichenzia Quoted in Bankrate Article Discussing Prominent IPOs to Keep an Eye On

Press Release – New York, NY – September 15, 2020 – Sichenzia Ross Ference founding partner Gregory Sichenzia was featured in a Bankrate article entitled “IPOs have gone red hot in 2020: Here are 7 big names to watch.” Sichenzia shared his opinion that with interest rates being at near record lows, investors are limited in where they can allocate capital, which is why the equities market and more specifically IPOs have been so attractive. Please read the full article here.

Sichenzia Ross Ference LLP Represents Vuzix in $15.5 Million Registered Direct Offering

vuzix

Press Release – New York, New York – September 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, in a registered direct offering of 3,647,060 shares of its common stock and 6 month common stock purchase warrants. The common stock was sold at a price of $4.25 per share and the warrants have an exercise price of $5.25 per share. The gross proceeds from the offering will be approximately $15,500,000. 

The Sichenzia Ross Ference LLP team was led by Partner Gregory Sichenzia, Counsel Jeffrey Cahlon, and Associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.2 Million Underwritten Public Offering of Avinger Inc. Common Stock

avinger logo

Press Release – New York, NY – August 26, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 11,063,830 shares of common stock of Avinger, Inc. (NASDAQ: “AVGR”), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD). The offering was made pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC).

continue reading >>

Sichenzia Ross Ference LLP Represents Roth Capital Partners, LLC as Sole Bookrunner in $23.5 Million Public Offering of Centrus Energy Corp. Common Stock

Centrus energy corp logo

Press Release – New York, NY – August 25, 2020 – Sichenzia Ross Ference LLP today
announced that it represented Roth Capital Partners, LLC as sole bookrunner, with Lake Street
Capital Markets LLC, as lead manager, in an underwritten public offering of 2,350,000 shares of
the common stock of Centrus Energy Corp. (NYSE American: LEU), a global energy company that
supplies low enriched uranium (“LEU”) for commercial nuclear power plants, at a price of
$10.00 per share.

continue reading >>

Sichenzia Ross Ference Partner Andrew M. J. Bernstein, Esq. Will Present at the Next Installment of The New York State Bar Association’s 2020 Trial Academy Virtual Conference Series: “Grand Jury Presentations and Representing Clients in the Grand Jury,” on Friday, August 21, 2020 from 2:00 – 4:00 p.m.

Sichenzia Ross Ference partner, and leader of the firm’s white-collar defense practice, Andrew M. J. Bernstein will be presenting at “Grand Jury Presentations and Representing Clients in the Grand Jury.” The presentation, which is Continuing Legal Education (“CLE”) accredited, is part of the New York State Bar Association’s (NYSBA) 2020 Trial Academy Virtual Conference series. The program will be held, on-line, Friday, August 21, 2020 from 2:00 – 4:00 p.m., and will also feature Catherine A. Christian, Esq., Senior Assistant District Attorney from the New York County District Attorney’s Office, Special Victims Bureau.

Mr. Bernstein will discuss what defense attorneys, representing individual and corporate clients, should consider before their clients appear before a grand jury as either a defendant in a criminal case, a target of an ongoing investigation or as a witness. Mr. Bernstein will also cover how to effectively prepare clients to testify in front of the grand jury and other crucial defense strategies to employ.

SIGN UP HEREProduct Code: 0HY3E

Founding Partner Gregory Sichenzia Participates on CLE Webinar Examining PIPEs and Registered Direct Offerings

Sichenzia Ross Ference founding partner Gregory Sichenzia participated in a webinar for Strafford, titled “PIPE Transactions and Registered Direct Offerings: Alternative Capital Raising, PE Investment Opportunity,” on Thursday, August 6. This presentation, which is Continuing Legal Education (“CLE”) accredited, examines the mechanics of traditional private investments in public equity (PIPEs) as well as registered direct offerings.

Among the topics reviewed by Sichenzia and other panel members were the following key issues:

  • What are the key advantages of PIPE transactions over a traditional offering of securities?
  • How has COVID-19 impacted public offerings of securities and the use of PIPEs as an alternative financing vehicle?
  • What are the essential terms and negotiating points for traditional PIPEs?
  • Why might a registered direct transaction be preferred over a standard PIPE transaction? Are there any additional registration requirements?

Please find the full link to the webinar here.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $6 Million Public Offering of Avinger Inc. Common Stock

avinger logo

Press Release – New York, NY – August 6, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 15,789,474 shares of the common stock of Avinger Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $0.38 per share. The offering was made pursuant to a registration statement on Form S-3 (No. 333-230124) which was previously filed with the Securities and Exchange Commission and declared effective on March 29, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $10 Million Initial Public Offering of 1847 Goedeker Inc. Common Stock

goedekers logo

Press Release – New York, NY – August 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, as sole book-runner in the initial public offering of the common stock of 1847 Goedeker Inc. (NYSE: GOED), a one-stop e-commerce destination for appliances, furniture, home goods, and related products. The offering was comprised of 1,111,200 shares of common stock at a price of $9.00 per share for gross proceeds of $10,000,800, less underwriting discounts and offering expenses. 

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in Close of $3.4 Million Underwritten Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – July 31, 2020 – Sichenzia Ross Ference LLP represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 453,333 shares of the company’s common stock at a price of $7.50 per share, for gross proceeds to DSS of $3.4 million, before deducting underwriting discounts and other offering expenses. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-230740), which was previously filed with the Securities and Exchange Commission and declared effective on May 8, 2019.

continue reading >>

Relief for Retirement Account Owners During COVID-19

The Coronavirus Aid, Relief, and Economic Security (CARES) Act that was signed into law on March 27, 2020 modifies the existing rules governing retirement accounts and helps taxpayers improve their cash flow. Here we highlight (1) the waiver of the 10% penalty applicable to early withdrawals, (2) the enhanced loan provisions, and (3) the suspension of the Required Minimum Distribution rules.  Please consult with your tax advisor to determine how you may take advantage of these new rules.

continue reading >>

Sichenzia Ross Ference LLP Represents Immuron Limited in $20 Million Registered Direct Offering

immuron logo

Press Release – New York, NY – July 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, in a registered direct offering of 1,066,668 American Depositary Shares (“ADSs”), each ADS representing 40 of the Company’s ordinary shares, at a purchase price of $18.75 per ADS for gross proceeds of approximately $20 million.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P/Alliance Global Partners in $5.9 Million Registered Direct Offering of Safe-T Group Ltd.

safe-t logo

Press Release – New York, NY – July 22, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of Safe-T Group Limited (NASDAQ: “SFET”) for gross proceeds of approximately $5.9 million. The offering provided for the issuance of an aggregate of (i) 3,075,000 American depositary shares (“ADSs”) at a purchase price of $1.40 per ADS, and (ii) 1,145,000 pre-funded warrants each to purchase one ADS (“Pre-Funded Warrants”) at a price of $1.40 each, including the Pre-Funded Warrant exercise price of $0.001 per full ADS. The Pre-Funded Warrants will be exercisable at any time after the date of issuance.  continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $5.1 Million Public Offering

genetic technologies logo

Press Release – New York, NY – July 20, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,025,000 American Depositary Shares (the “ADSs”), each representing six hundred of the Company’s ordinary shares, at a purchase price of $5.00 per ADS, for gross proceeds of $5.1 million.

continue reading >>

Sichenzia Ross Ference LLP Represents Zynex, Inc. and Selling Shareholder in $55 Million Public Offering of Common Stock

zynexmedical logo

Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP today announced that it represented Zynex, Inc. (NASDAQ: “ZYXI”), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, and a certain shareholder in a public offering of an aggregate of 2,500,000 shares of its common stock at a public offering price of $22.00 per share. The offering was made pursuant to a registration statement on Form S-3 (File No. 333-230128) that was filed with the Securities and Exchange Commission (the “SEC”) and became effective on March 12, 2019, and a registration statement on Form S-3 (File No. 333-232367) that was filed with the SEC and became effective on July 3, 2019, for the shares of common stock being offered by ZYXI and the selling stockholder, respectively.

continue reading >>

Sichenzia Ross Ference LLP Represents INmune Bio, Inc. in $21.74 Million Public Offering of Common Stock

inmunebio logo

Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP announced that it represented INmune Bio Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, in a public offering of 2,173,914 shares of the company’s common stock at a price of $10.00 per share.  The gross proceeds to INMB were $21.74 million, before deducting underwriting discounts and other offering expenses, with net proceeds estimated to be $20 million. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-237368), that was filed with the Securities and Exchange Commission (the “SEC”) and became effective on April 2, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Equillium, Inc. in $150 Million At-The-Market Offering Through Jeffries LLC 

equilliam logo

Press Release – New York, NY – July 16, 2020 – Sichenzia Ross Ference LLP announced that it represented Equillium, Inc. (NASDAQ: “EQ”), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, in an At-The-Market Offering (“ATM”), whereby Equillium may sell up to $150 million of common stock from time-to-time.  Jefferies LLC is acting as the sales agent in connection with the ATM.

continue reading >>

Sichenzia Ross Ference LLP Represents H.C. Wainwright as Sales Agent in $7 Million At-The-Market Offering of BioPath Holdings

bio-path holdings inc logo

Press Release – New York, NY – July 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC, as sales agent in an At-The-Market Offering (“ATM”) of BioPath Holdings Inc (NASDAQ: “BPTH”) common stock for gross proceeds of approximately $7 million. The shares were registered on BPTH’s Registration Statement on Form S-3 (File No. 333-231537) filed with the Securities and Exchange Commission on May 16, 2019, and declared effective by the SEC on June 5, 2019, and the prospectus supplement relating to the ATM filed with the SEC on July 14, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6.43 Million Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – July 7, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 1,028,800 shares of the company’s common stock at a price of $6.25 per share, for gross proceeds to DSS of $6.43 million, before deducting underwriting discounts and other offering expenses. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-230740), which was previously filed with the Securities and Exchange Commission and declared effective on May 8, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.4 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – June 26, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 20,000,000 shares of Avinger, Inc. (NASDAQ: AVGR) common stock at a price of $0.27 per share, for total gross proceeds of approximately $5.4 million.  Avinger is a leading developer of innovative treatments for peripheral artery disease. 

continue reading >>

Sichenzia Ross Ference LLP Represents Hudson Capital Inc. in $3.7 Million Registered Direct Offering 

china internet nationwide financial services

Press Release – New York, NY – June 24, 2020 – Sichenzia Ross Ference LLP today announced that it represented Hudson Capital Inc.  (NASDAQ: HUSN), in a $3.7 million registered direct offering of its ordinary shares at a price of $0.85 per share. The offering was made pursuant to a registration statement on Form F-3 (File No. 333-233408) which was previously filed with the Securities and Exchange Commission and declared effective on September 19, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6 Million Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – June 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 769,230 shares of the company’s common stock at a price of $7.80 per share. The offering was made pursuant to a registration statement on Form S-1 (File No. 333-238587) which was previously filed with the Securities and Exchange Commission and declared effective on June 16, 2020. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.4 Million Public Offering of Digital Ally, Inc. Common Stock

digital ally logo

Press Release – New York, NY – June 5, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,325,581 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company, at a price of $2.15 per share. The underwriters elected to simultaneously close the over-allotment option consisting of 213,953 shares of common stock, bringing the offering’s gross proceeds to approximately $5.4 million, before deducting underwriting discounts and other offering expenses.

continue reading >>

Founding Partner Marc J. Ross, Esq. Presents Legal Webinar on The Ethical Considerations for an Attorney Advising Clients Engaged In a Marijuana-Related Business

Sichenzia Ross Ference founding partner Marc J. Ross, Esq. will be presenting a webinar course for the Clear Law Institute, titled “The Ethical Considerations for an Attorney Advising a Client Engaged In a Marijuana-Related Business,” on Friday, June 12, 2020 at 3:00 pm. This presentation, which is Continuing Legal Education (“CLE”) accredited, will explore the ethical concerns and practices related to attorneys advising clients that are engaged in marijuana-related business.

To register and participate in this Webinar, please visit the website here include speaker code MRoss291348 for a 35% discount, and pass it along to anyone you think might be interested.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.1 Million Public Offering of Digital Ally, Inc. Common Stock

digital ally logo

Press Release – New York, NY – June 5, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 3,090,909 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company. The stock was offered at $1.65 per share for gross proceeds of approximately $5.1 million, less underwriting discounts and other offering expenses.

continue reading >>

“Regulation Best Interest” Is Nearly Here. What Regulators Want to See. What Broker-Dealers Need to Know and Do.

On June 5, 2019, the United States Securities and Exchange Commission (“Commission”) adopted Rule 15l-1 (“Regulation Best Interest” or “Reg. BI”) under the Securities Exchange Act of 1934 (“Exchange Act”), which has a compliance date of June 30, 2020.[1] What broker-dealers and their compliance and supervisory personnel need to know and do to prepare for July 1, 2020 is priority number one.  This second article in this series examining Reg. BI provides tips and tools for, in particular, independent broker-dealers to consider what needs to be done by July 1, 2020 and the balance of the year.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $8 Million Public Offering

genetic technologies logo

Press Release – New York, NY – May 28, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a public offering of 4,000,000 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman, counsel Jeffrey Cahlon, and associate Yian Pan.

Marc J. Ross, Esq. Presents a Legal Webinar Explaining the Confusion Surrounding Marijuana Law

Having just finished teaching his fifth successful year of “The Business and Law of Marijuana” at Hofstra University School of Law, SRF founding partner Marc J. Ross, Esq. recently presented a webinar course for the Clear Law Institute, titled “Weeding Out the Confusion in Marijuana Law.”

This webinar, which is Continuing Legal Education (“CLE”) accredited, took place on Monday, May 11, 2020 at 3:00 pm. During the presentation, Marc discussed the confusing and often contradictory laws concerning marijuana for marijuana-related businesses and, amongst other things, address how current federal law remains in stark contrast to the majority of state laws; explain the origins and development of the differing current laws; identify certain areas of the law that should be particularly concerning; and finally, delineate how and why CBD is different, both on the federal and state level.

To access this webinar, please visit the website and include speaker code MRoss289594 for a 35% discount.

 

Sichenzia Ross Ference Founding Partner Marc J. Ross, Esq. to Present Legal Webinar on Federal Regulation Governing Marijuana-Related Businesses

Sichenzia Ross Ference founding partner Marc J. Ross, Esq will present a webinar course for the Clear Law Institute, titled “Federal Regulation Governing the Operation of Marijuana-Related Business,” on Tuesday, May 26, 2020 at 3:00 pm.

This presentation, which is Continuing Legal Education (“CLE”) accredited, we will explore how Federal law enforcement and other Federal regulatory agencies govern and impact the operation of marijuana-related business. Upon course completion, you will be able to recognize, identify, and describe:

  • Potential criminal issues raised by the United States Department of Justice
  • Potential banking issues raised by the United States Department of Treasury
  • Potential tax issues raised by the United States International Revenue Code
  • Potential issues with securities as raised by the United States Securities and Exchange Commission and United States listed exchanges
  • Potential insolvency issues related to the United States bankruptcy laws

To register and participate in this Webinar, please visit the website here and include speaker code MRoss290814 for a 35% discount, and pass it along to anyone you think might be interested.

Sichenzia Ross Ference LLP Represents ThinkEquity in $5 Million Public Offering of Medigus Ltd 

Medigus Ltd logo

Press Release – New York, NY – May 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager in a $5 million offering of Medigus Ltd. (Nasdaq: MDGS), an Israeli technology company developing minimally-invasive tools and direct visualization technology.  

continue reading >>

Estate Planning During COVID-19

COVID-19 is a harsh reminder that life is fragile and unpredictable. The pandemic has caused many people to acknowledge their mortality and to reevaluate their financial circumstances and life goals.  In these rather difficult and uncertain times, the importance of being prepared for a worst-case scenario and having certain essential estate planning documents in place is, unfortunately, paramount.  At a minimum, every client should establish (or update) the following in order to protect themselves, their loved ones, and their legacy:

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $11,250,000 Registered Direct Offering

vuzix view the future logo

Press Release – New York, New York – May 13, 2020 – Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI) in a registered direct offering of 5,000,000 shares of its common stock at a price of $2.25 per share for gross proceeds of approximately $11,250,000. 

The Sichenzia Ross Ference LLP team was led by partner Gregory Sichenzia, counsel Jeffrey Cahlon, and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement 

lexaria bioscience logo

Press Release – New York, New York – May 7, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common stock and warrants for gross proceeds of approximately $2 million. 

The Special Equities Group, a division of Bradley Woods & Co. Ltd., acted as the exclusive placement agent for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital in $3.15 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – April 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 12,600,000 shares of Avinger, Inc. (NASDAQ: AVGR) common stock at a price of $0.25 per share, for total gross proceeds of approximately $3.15 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

60 Days And Counting: “Regulation Best Interest” Is Nearly Here. Are Independent Broker-Dealers Ready? What They Need to Know and Do

On June 5, 2019, the United States Securities and Exchange Commission (“Commission”) adopted Rule 15l-1 (“Regulation Best Interest”) under the Securities Exchange Act of 1934 (“Exchange Act”), which has a compliance date of June 30, 2020.[1]  Regulation Best Interest became effective September 10, 2019.  Notwithstanding the host of issues arising from the global pandemic, an economic recession and significant market volatility across essentially every sector, the Commission has made clear that the deadline for compliance with Regulation Best Interest and the related Form CRS requirements will not be delayed or extended.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners in $8.4 Million Underwritten Public Offering of Safe-T Group Ltd.

safe-t logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented A.G.P./Alliance Global Partners as sole book-running manager in an underwritten public offering of the securities of Safe-T Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments. The securities offered by the company consisted of (i) 858,600 units, each comprised of one American Depositary Share (“ADS”), representing 40 ordinary shares, and one warrant to purchase one ADS (“Warrant”), and (ii) 6,777,500 pre-funded units, each comprised of one pre-funded warrant to purchase one ADS and one Warrant.  The offering price was $1.10 per unit and $1.099 per pre-funded unit. 

continue reading >>

Sichenzia Ross Ference LLP Represents Beyond Air in $50 Million At-The-Market Offering

beyond air logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, in an At-The-Market Offering (“ATM”) under which the Company may offer and sell from time to time shares of its common stock having an aggregate offering price of up to $50,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.44 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 722,502 American Depositary Shares (ADSs), each representing 600 of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.8 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 3, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,028,574 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $1.75 per ADS.

continue reading >>

SEC Extends Filing Deadlines for Public Companies and Registered Investment Advisers Affected by COVID-19

On March 25, 2020, the Securities and Exchange Commission (the “SEC”) issued new orders extending the filing periods covered by its previously enacted conditional reporting relief for certain public company filing obligations under the federal securities laws, and also extended regulatory relief previously provided to funds and investment advisers whose operations may be affected by COVID-19.

continue reading >>

Business Interruption Insurance

Dear Clients and Friends,

With widespread government ordered shutdowns resulting from the COVID-19 pandemic, companies are understandably concerned with the interruption to their business operations as well as the financial and economic losses that are beginning to mount. In light of this, it is important that companies take the time to look at their existing insurance policies to examine what options are available to mitigate the impact of the COVID-19 pandemic. The viability of a claim for losses under your existing Property, Event and/or Comprehensive General Liability policies caused by a pandemic or “communicable or infectious diseases” will be largely subject to the specific provisions of your company’s insurance policies.

Sichenzia Ross Ference LLP recommends that all its clients carefully review their insurance policies, including without limitation their Property, Event and Commercial General Liability policies, to determine the scope of coverage for business interruption with particular focus on whether any of those policies include or exclude coverage for losses caused by a communicable or infectious disease such as COVID-19.

We, at Sichenzia Ross Ference LLP, continue to think about our clients and friends during these trying times, and, if there are any ways we might be able to help, ask that you contact us.

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $7.7 Million Overnight Bought Offering of Cel-Sci Common Stock

cel sci

Press Release – New York, NY – March 26, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book-running manager in an offering of 630,500 shares of the common stock of Cel-Sci Corporation (NYSE American: CVM), a biotechnology company. The stock was offered at $12.22 per share for gross proceeds of approximately $7.7 million, less underwriting discounts and other offering expenses.  

continue reading >>

Coronavirus (Covid 19) Update

At Sichenzia Ross Ference LLP, people are our priority. As the world struggles to manage through the impact of the coronavirus (COVID-19), we want to assure you that we are committed to supporting our colleagues, clients, friends and communities as effectively as we have through every other crisis over the decades.

  • Our firm is fully operational: We have adapted and activated our business continuity plans to ensure that our lawyers and team members are able to safely serve our clients’ needs and continue operations on an uninterrupted basis, whether working from our offices or remotely.
  • We encourage you to contact us with any concerns that you may have or topics that you would like to discuss; we are here to support you through these challenging times. Please continue to contact us at the same phone numbers and email addresses that you are accustomed to using.
  • As disruptive as these days are for our clients and colleagues, we know that this virus and efforts to stop its spread will have an even greater impact on the most vulnerable members of our society. Our thoughts go out to all those whose health has been or will be affected by this virus, and our gratitude goes to all the first responders and health care workers courageously working every day to help those who are ill.

We are all in this together, and we will get through it together.

Our thoughts are with you and your loved ones to stay safe and be well.

Founding Partner Gregory Sichenzia Featured in Law360 Article on Coronavirus-fueled Market Volatility

Press Release – New York, NY – March 10, 2020 – Sichenzia Ross Ference LLP today shared that founding name partner Gregory Sichenzia was quoted in Law360 by reporter Tom Zanki in his story, “Market Turbulence Throws IPO Pipeline Into Question.” The story discussed market volatility and IPO plans amid the coronavirus outbreak, including commentary from Sichenzia:

No IPOs are scheduled yet for next week, according to New York Stock Exchange and Nasdaq calendars. Sichenzia Ross Ference LLP partner Greg Sichenzia expects that companies that have not launched roadshows yet will wait for stability before moving forward.

“If you can keep your powder dry, you will,” said Sichenzia, who counsels public and private companies.

Sichenzia Ross Ference LLP Represents Pareteum Corporation in $3.75 Million Offering of Series C Preferred Stock

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Pareteum Corporation (NASDAQ: TEUM), a cloud communications platform company, as it entered into a subscription agreement with certain investors for shares of the company’s 8% Series C Redeemable Preferred Stock at a purchase price of $100,000 per share for gross proceeds of $3,750,000.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associate Grant Levine.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $2.9 Million Public Offering of Digital Ally, Inc. Common Stock 

digital ally logo

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,521,740 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company. The stock was offered at $1.15 per share for gross proceeds of approximately $2.9 million, less underwriting discounts and other offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Alliance Global Partners as Placement Agent in $10M Registered Direct Offering of Aptorum Group Limited

Aptorum logo

Press Release – New York, NY – February 28, 2020 – Sichenzia Ross Ference LLP announced today that it represented Alliance Global Partners as lead placement agent in a registered direct offering of 1,351,350 Class A ordinary shares of Aptorum Group Limited (Nasdaq: “APM”), a biopharmaceutical company. The offering price was $7.40 per share for gross proceeds of $10 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $4.6 Million Public Offering of Common Stock 

document security systems logo

Press Release – New York, NY – February 25, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and diversion protection technologies, in the underwritten public offering of 22,222,223 common shares, plus 3,333,333 shares from the exercise of the underwriter’s purchase option to cover overallotments, at a price of $0.18 per share for gross proceeds of $4.6 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.6 Million Offering of Medalist Series A Stock

medalist diversified reit logo

Press Release – New York, NY – February 19, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 200,000 shares of 8% Series A Cumulative Redeemable Preferred Stock of Medalist Diversified REIT, Inc. (Nasdaq:MDRR), a real estate investment trust specializing in the acquisition, ownership and management of value-add commercial real estate.  The shares were sold at an offering price of $23.00 per share for gross proceeds of $4.6 million and commenced trading on the Nasdaq Capital Market under the symbol “MDRRP.”

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $8.1 Million Offering and NASDAQ Listing of Duos Technologies Common Stock

duostech logo

Press Release – New York, NY – February 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager and The Benchmark Company as co-manager in an $8.1 million offering of common stock at $6.00 per share of Duos Technologies Group, Inc. (NASDAQ: DUOT). Simultaneously with the offering, the common stock was approved for listing on the Nasdaq Capital Market and began trading on February 13, 2020 under the symbol DUOT. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Follow-On Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – February 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 6,428,572 shares of the common stock of Avinger, Inc.  (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease, at an offering price of $0.70 per share for gross proceeds of $4.5 million. The shares are being offered and sold pursuant to Avinger’s effective registration statement on Form S-1 (Registration No. 333-235902).

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P. in $2.2 Million Common Stock Offering

co crystal pharma inc

Press Release – New York, NY – January 31, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a $2.2 million offering of common stock at $0.63 per share of Cocrystal Pharma, Inc.  (NASDAQ: COCP), a clinical stage biotechnology company developing antiviral therapeutics.  The shares were offered and sold pursuant to Cocrystal’s effective registration statement on Form S-3 (Registration No. 333-220632).

continue reading >>

Sichenzia Ross Ference LLP Represents HiVentures Zrt., a Hungarian Venture Capital Company, in Private Placement of Series A Preferred Stock of ActiveGraf

activegraf logo

Press Release – New York, NY – January 16, 2020 – Sichenzia Ross Ference LLP announced today that it represented MFB Növekedési Tökealap, a Hungarian investment firm, and its manager, Hiventures Zrt., a state-owned venture capital company committed to the promotion of Hungarian start-ups and businesses, in connection with their agreement to purchase approximately $900,000 of Series A preferred stock of ActiveGraf Inc., a private North Carolina-based company creating interactive data analytics.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $3M Registered Direct Offering of Cellect Biotechnology Ltd.

cellect logo

Press Release – New York, NY – January 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of 1,000,000 American Depositary Shares (“ADSs”) of Cellect Biotechnology Ltd (Nasdaq: “APOP”), a developer of innovative technology enabling the functional selection of stem cells. Each of the ADSs represents 100 of APOP’s ordinary shares. The offering price was $3.00 per ADS for gross proceeds of approximately $3,000,000, less fees and other estimated offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Successfully Defends Client in Hostile Proxy Contest

Press Release – New York, NY – January 7, 2020 – Sichenzia Ross Ference LLP successfully defended its client, Document Security Systems, Inc., against dissident shareholders.  The shareholders abandoned their efforts after filing an insurgent proxy statement relating to the company’s December 9, 2019 annual meeting. The meeting was held as scheduled and the Board’s recommended slate of candidates was elected.

The SRF team was led by partners Gregory Sichenzia, Darrin Ocasio, Marcelle Balcombe, Barrett DiPaolo, and Jay Yamamoto and associate Matthew Siracusa.

SRF CLIENT ALERT: Major Changes for Your IRA Account

Congress has made major changes for IRA accounts effective January 1, 2020:

The End of the Stretch IRA

Before 2020, anyone who inherited an IRA account was able to delay taking distributions from it over the course of his or her lifetime.  This frequently enabled the IRA beneficiary to stretch out the mandatory withdrawals over many decades, meanwhile allowing the IRA account to build up on a tax-deferred basis.  Beginning in 2020, with certain exceptions, anyone who inherits an IRA will have to take all of it out within 10 years.  The timing of the withdrawals during the 10 years is up to the beneficiary, but by the end of 10 years the entire account has to be taken down and all of the deferred income taxes have to be paid.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.5 Million Follow-On Offering of CEL-SCI Corporation Common Stock

cel sci

Press Release – New York, NY – December 30, 2019 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 606,395 shares of the common stock of CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, at an offering price of $9.07 per share, for gross proceeds of $5.5 million. Pursuant to the terms of the underwriting agreement, Aegis has been granted a 45-day option to purchase up to an additional 90,959 shares of CEL-SCI common stock to cover over-allotments.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio, Avital Perlman and Marcelle Balcombe and associates Grant Levine and Jacob Tabman.

Sichenzia Ross Ference LLP Represents Biotricity Inc. in a $6 Million Private Placement of its Series A Convertible Preferred Stock

biotricity logo

Press Release – New York, New York – December 19, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, in connection with the sale of $6M of its Series A convertible preferred stock.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia and David Manno.

Sichenzia Ross Ference LLP Achieves Voluntary Dismissals in Federal Securities Class Action Lawsuit and Shareholder Derivative Action

Press Release – New York, NY – December 16, 2019 – Sichenzia Ross Ference LLP (SRF) achieved voluntary dismissals in two lawsuits on behalf of its client, Vuzix Corporation (“Vuzix” or “Company”), a leading developer and supplier of Smart Glasses and Augmented Reality Glasses.  SRF represented the Company in consolidated class action lawsuits alleging violations of federal securities laws before the United States District Court for the Southern District of New York (“Class Action”), and in consolidated shareholder derivative actions before the New York State Supreme Court for Monroe County (“Derivative Action”).  The Plaintiffs ultimately dropped both actions.

continue reading >>

Sichenzia Ross Ference LLP Represents Beyond Air, Inc. in a $11.5 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement

beyond air logo

Press Release – New York, NY – December 12, 2019 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a clinical stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for treatment of severe respiratory conditions, in the successful completion of an underwritten public offering and concurrent private placement of approximately $11.5 million of Beyond Air common stock at a price of $3.66 per share. The public offering was conducted from an effective shelf registration statement filed with the Securities and Exchange Commission.  The private placement shares will not be registered.

continue reading >>

Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock

relmada

Press Release – New York, NY – December 6, 2019 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a clinical stage company developing depression and central nervous system disease therapies, in the successful completion of an underwritten public offering of three million shares of Relmada common stock at a price of $30.00 per share.

The underwriters exercised their over-allotment option for an additional 450,000 shares, bringing gross proceeds to $115 million before the deduction of underwriting discounts, commissions, and other estimated offering expenses. Jefferies, SVB Leerink, and Guggenheim Securities are joint book running managers for the offering.

Relmada intends to use the net proceeds to fund research and development for clinical stage programs related to its lead product candidate, REL-1017 (d-methadone), an oral agent for depression which recently produced favorable results in clinical trials.

Sichenzia Ross Ference LLP also represented Relmada in the listing of its Common Stock on the Nasdaq Capital Market, which commenced trading on October 10, 2019. The firm joined Relmada and its executive leadership at its Nasdaq Bell Ringing Ceremony on October 17.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Barrett DiPaolo, Thomas Rose and Associate Grant Levine.

Sichenzia Ross Ference Trust & Estate Attorneys Quoted in LegalZoom Article

Press Release – New York, NY – December 6, 2019Sichenzia Ross Ference (SRF) trust and estate attorneys Jodi Zimmerman and Robert Birnbaum were quoted in a LegalZoom article entitled Including Your Stepchildren in Your Estate Plan, written by Sandra Beckwith. Zimmerman and Birnbaum elaborate on tips for preparing wills and trusts to include stepchildren and how to effectively communicate your wishes to loved ones.

You can read the full article here.

Sichenzia Ross Ference Represents H-Cyte, Inc. in $6.0 Million Private Placement

H-Cyte

Press Release – New York, NY – December 2, 2019 –  Sichenzia Ross Ference LLP acted as H-Cyte’s counsel in a $6.0 million private placement with FWHC, LLC at a price in excess of the market price. H-Cyte is the owner and operator of innovative medical technology products and services including LungCYTE and The Lung Health Institute. H-Cyte intends to utilize the funds to advance its development of industry-leading medical treatments for chronic lung diseases such as COPD. The SRF team was led by partner, Arthur Marcus.

Time to Make a Personal Estate Plan for Your (Financial) Exit or IPO

Your years of hard work have finally come to fruition.  Your company is going to go public or your business is going to be sold and what was once a dream is now about to become a reality.  This is the time when many entrepreneurs make million-dollar mistakes and forget about their partner Uncle Sam.  He has been waiting patiently in the wings for you to get rich; the richer you get, the happier he is.

The United States does not have a wealth tax yet, and it may never have one unless Elizabeth Warren is elected President.  However, it does have a death tax and so do a number of states, including New York; the less you plan the higher the death tax will be.  Whether your company will be going public or will be sold privately, you will be in a position to potentially save millions in estate taxes by putting a solid estate plan in place to protect your family.

Here’s the bad news: right now, the federal government has a death tax that will take 40% of everything you own over $11,400,000.  The amount exempt from tax is scheduled to be cut in half in a few years and possibly sooner, depending on the 2020 election.  Many States take a bite as well; for example if you live in New York, the State government has a death tax with rates that could take up to 16% of your assets.

But there’s good news: your company going public or selling your business presents you with an opportunity to potentially save millions in taxes.  It also enables you to structure a plan that will benefit your family and provide for their future well-being for many decades to come.  For more information and guidance on how this can be accomplished, please get in touch with Robert Birnbaum at rbirnbaum@srf.law or Jodi Zimmerman at jzimmerman@srf.law of our Trusts and Estates department. You can also call our office at (212) 930-9700 to speak with our attorneys.

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $3.5 Million Public Offering for Safe-T Group Ltd.

safe-t

Press Release – New York, NY – November 5, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and warrants of Safe-T Group Ltd., a provider of Secure Access solutions for on-premise and hybrid cloud environments (NASDAQ, TASE: SFET).

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in a $1.8 Million Private Placement

document security systems logo

New York, NY – November 5, 2019 – Sichenzia Ross Ference LLP, announced today that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and consumer engagement technology, in a private placement of 6,000,000 shares of the company’s common stock at a purchase price of $0.3037 per share. DSS received gross proceeds of $1,822,200 from the offering, which was funded entirely by the company’s Chairman of the Board of Directors, Mr. Heng Fai Ambrose Chan. continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

co crystal pharma inc

Press Release – New York, NY – November 4, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics. continue reading >>

Sichenzia Ross Ference LLP Ranked as a Top Issuer Counsel for 2019 Q3

srf square banner

Press Release – New York, NY – October 23, 2019 – PlacementTracker, part of the Business Intelligence Division of Informa PLC, has ranked Sichenzia Ross Ference LLP among the most active issuer counsels in the U.S. PIPE and private placement markets for the third quarter of 2019 by the number of transactions, representing issuers in over $50 million of placed securities. Read PlacementTracker’s full press release here.

Attorneys Selected for Inclusion on 2019 Super Lawyers Lists

Press Release – New York, NY – October 15, 2019 – Sichenzia Ross Ference LLP, a leading corporate and securities law firm, announced today that seven of its attorneys were recognized by Super Lawyers Magazine for 2019. Those Sichenzia Ross members include:

  • Partner A.R. John Hitchings, Partner Jay Yamamoto, Associate Owen A. Kloter, and Associate Gary Varnavides were all named New York Metro Rising Stars for 2019
  • Founding Partner Michael Ference and Partner Sameer Rastogi were recognized for their work in the Securities Litigation category
  • Founding Partner Gregory Sichenzia was recognized for his work in the Securities and Corporate Finance category

Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing

Press Release – New York, NY – October 15, 2019Sichenzia Ross Ference LLP founding partner Gregory Sichenzia will join representatives of client Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical stage, specialty pharmaceutical company, focused on treatment solutions for depression, CNS and ophthalmological disorders, at the Nasdaq MarketSite in Times Square to ring the October 18 opening bell.

Mr. Sichenzia will take the stage along with a group of Relmada Therapeutics leaders, including Chief Executive Officer Sergio Traversa, PharmD, MBA. You can tune in October 18 at 9:30am EST on Facebook Live or via the Nasdaq Webcam. 

Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting

New York, NY – October 10, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by Gregory Sichenzia and partner Barrett DiPaolo. The up-listing is effective for trading on October 10, 2019, and RLMD’s common stock will trade under its existing stock symbol, “RLMD.”

continue reading >>

1 2 3 6